The International Diabetes Federation 2019 Congress has selected Mater’s Professor David McIntyre to provide the prestigious ‘Stream Award Lecture’ at this year’s meeting.

04

Mar

Professor David McIntyre selected to present prestigious lecture

A $40,000 grant has been awarded to the Mater Research Institute—University of Queensland (MRI-UQ) to develop a parent-version of the national clinical guidelines on care around stillbirth.

22

Feb

New funding to better support parents touched by stillbirth

Mater Research—University of Queensland (MRI—UQ) Acting Director Professor Maher Gandhi has been awarded $3.6 million to improve treatment for relapsed lymphoma patients.

18

Feb

$3.6 million awarded to develop treatment for relapsed lymphoma patients

Dr Seth Cheetham has been awarded three grants to fund research projects addressing the role of genomic plasticity in cancer treatment.

12

Feb

Mater Researcher secures trio of funding for cancer research

Cognitive Neurologist Professor Peter Nestor has been appointed to the position of Clinical Program Leader of the Neurosciences and Cognitive Health Program at Mater.

11

Feb

Professor Nestor appointed Clinical Program Leader of Neurosciences at Mater

A Mater researcher has developed a method to predict breast cancer patient responses to a commonly prescribed breast cancer drug.

04

Feb

New test predicts breast cancer patients at risk of relapse

Simulation is a valuable tool used to educate and train health professionals.

29

Jan

Simulator realism establishes scenario that learners embrace

Professor Vicki Flenady and her team at the Stillbirth Centre of Research Excellence (CRE) were awarded the UQ Faculty of Medicine Collaborators of the Year Award.

24

Jan

Mater researchers recognised for their extensive collaborations

As of Thursday 24 January 2019 it will be a mandatory requirement for signatures to be collected in electronic format only on the Mater SSA.

23

Jan

Changes to Site-Specific Assessment Submissions at Mater

Dr Peter Steer has commenced his appointment as Mater Group Chief Executive Officer.

09

Jan

New Mater Group CEO takes the reins

Researchers from Mater Research have been awarded more than $1.84 million in National Health and Medical Research Council (NHMRC) funding.

12

Dec

Mater Research awarded $1.84 million in NHMRC funding

Mater researchers have shown that new applications of existing drugs has the potential to improve quality of life for people with Myasthenia gravis

06

Dec

New applications of drugs could reduce side effects for Myasthenia gravis patients

Displaying results 49-60 (of 159)
 |<  <  1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >  >|